Vitalhub Corp. (TSE:VHI - Get Free Report) passed above its two hundred day moving average during trading on Thursday. The stock has a two hundred day moving average of C$7.64 and traded as high as C$7.75. Vitalhub shares last traded at C$7.71, with a volume of 70,877 shares traded.
Analyst Upgrades and Downgrades
Separately, Canaccord Genuity Group set a C$15.00 target price on shares of Vitalhub and gave the stock a "buy" rating in a research report on Friday, August 28th. Six investment analysts have rated the stock with a Buy rating. Based on data from MarketBeat, Vitalhub has a consensus rating of "Buy" and an average target price of C$12.67.
Get Our Latest Research Report on VHI
Vitalhub Trading Up 2.4%
The business has a fifty day simple moving average of C$7.65 and a two-hundred day simple moving average of C$7.64. The stock has a market cap of C$487.73 million, a PE ratio of 64.25, a P/E/G ratio of 1.18 and a beta of 1.40.
Vitalhub (TSE:VHI - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.03 EPS for the quarter. Vitalhub had a return on equity of 2.79% and a net margin of 5.89%. The company had revenue of C$31.74 million during the quarter. On average, research analysts predict that Vitalhub Corp. will post 0.23 earnings per share for the current year.
About Vitalhub
(
Get Free Report)
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.